Topography-Guided Customized PRK Versus Q-value Adjusted PRK in Correction of Myopia With or Without Astigmatism
1 other identifier
interventional
104
1 country
2
Brief Summary
This study will include patients who will undergo PRK in both eyes, for each patient each eye will be randomly allocated to one of 2 procedures: topography-guided ablation in one eye (group I) and Q-factor customized ablation in the other eye (group II). Alcon/Wavelight Light Laser Technolo¬gie (GmbH, Erlangen, Germany) will be used for photoablation. The wavelight Topolyzer (Wavelight AG, Erlan¬gen, Germany)and CSO Sirius scheimpflug camera combined with Placido corneal topography (CSO, Florence,Italy) will be used before and 1, 3 and 6 months after PRK. Refrac¬tive visual outcomes and corneal aberration changes will be compared between the two treatment modalities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2017
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2017
CompletedFirst Posted
Study publicly available on registry
September 25, 2017
CompletedStudy Start
First participant enrolled
October 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 25, 2019
CompletedJuly 7, 2020
July 1, 2020
1.7 years
August 8, 2017
July 1, 2020
Conditions
Outcome Measures
Primary Outcomes (7)
change in Postoperative spherical equivalent depending on manifest refraction after autorefractometer
1 , 3 and 6 months postoperative
change in visual acuity using snellen chart
1 , 3 and 6 months postoperative
change in corneal wavefront aberrations
assessed by topolyzer
1 , 3 and 6 months postoperative
change in Q value anterior at 6mm RMS, RMS of astigmatism, RMS of coma and RMS of spherical aberrations. Strehl ratio : Qvalue,RMS,strehl ratio by CSO Sirius scheimpflug
by CSO Sirius scheimpflug
1,3 and 6months
change in total RMS
by CSO Sirius scheimpflug
1,3 and 6months
change in strehl ratio
by CSO scheimpflug
1,3 and 6 months
change in Q value
assessed by topolyzer
1,3 and 6 months
Secondary Outcomes (5)
efficacy:ratio of postoperative decimal UDVA to preoperative decimal CDVA
6 months
contrast sensitivity
6 months
predictability
6 months
safety:ratio of mean preoperative decimal CDVA to mean postoperative decimal CDVA
6 months
stability
6 months
Study Arms (2)
topography guided PRK in one eye
ACTIVE COMPARATORTopography-guided (placido disk- based) using T-CAT Contoura treatment.
Q-value adjusted ( custom Q) PRK in the other eye
ACTIVE COMPARATORThe target Q will be estimated according to a nomogram considering the patient's age
Interventions
PRK using Alcon-Wavelight Excimer Laser EX 500
Eligibility Criteria
You may qualify if:
- Age more than 18 years
- Myopia with up to -6.5 D with or without astigmatism up to -4.75 D
You may not qualify if:
- anterior segment abnormalities (ie, cataracts, corneal scarring)
- basement membrane disease
- history of recurrent corneal erosions
- Schirmer's test less than 5 mm
- established or forme fruste keratoconus
- macular or retinal disease
- current use of immunosuppressive therapy
- autoimmune disease
- pregnancy, and lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Eyecare centre
Maadi, Cairo Governorate, Egypt
Dar Al Oyun hospital
Giza, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assisstant lecturer Faculty of Medicine Helwan University
Study Record Dates
First Submitted
August 8, 2017
First Posted
September 25, 2017
Study Start
October 25, 2017
Primary Completion
June 25, 2019
Study Completion
June 25, 2019
Last Updated
July 7, 2020
Record last verified: 2020-07